Skip to content
Medical Health Aged Care

Music can stave off dementia by up to 40 per cent, Monash study finds

Monash University 2 mins read

Listening to music when you are over 70 years of age has been linked to a 39 per cent      reduction in the risk of dementia, according to a Monash University-led study of over 10,800 older people.

The study, led by Monash honours student Emma Jaffa, and Professor Joanne Ryan, looked at the benefits of listening to music or playing music in people aged over 70, finding that always listening to music compared with never/rarely/sometimes listening to music was associated with a 39 per cent decreased risk of dementia. While playing an instrument was associated with a 35 per cent reduction in dementia risk.

This study used data from the ASPirin in Reducing Events in the Elderly (ASPREE) study, and the ASPREE Longitudinal Study of Older Persons (ALSOP) substudy and was published in the International Journal of Geriatric Psychiatry.

The study found that always listening to music was associated with the greatest reduction in dementia risk, with a 39 per cent lower incidence of dementia and 17 per cent lower incidence of cognitive impairment, as well as higher scores in overall cognition and episodic memory (used when recalling everyday events). While regularly engaging in both music listening and playing was associated with a 33 per cent decreased risk of dementia and 22 per cent      decreased risk of cognitive impairment.

According to Ms Jaffa     , the findings of the study “suggests music activities may be an accessible strategy for maintaining cognitive health in older adults, though causation cannot be established,” she said.

Population ageing has become a global public health concern due to advances in medicine and technology extending human lifespans, and this longer life expectancy has also meant an increase in the prevalence of agerelated diseases, including cognitive decline and dementia.

With no cure currently available for dementia, the importance of identifying strategies to help prevent or delay onset of the disease is critical,” senior author Professor Ryan said.

“Evidence suggests that brain ageing is not just based on age and genetics but can be influenced by one's own environmental and lifestyle choices. Our study suggests that lifestyle-based interventions, such as listening and/or playing music can promote cognitive health.”

Read the full paper in the International Journal of Geriatric Psychiatry: What is the association between music-related leisure activities and dementia risk? A cohort study. DOI: 10.1002/gps.70163

 

More from this category

  • Medical Health Aged Care
  • 09/01/2026
  • 23:40
Dark Horse Consulting Group

Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine

WALNUT CREEK, Calif. and NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, is pleased to announce the acquisition of Bruder Consulting & Venture Group (“Bruder” or “BCVG”), a strategic advisory and consulting firm with a global footprint in biotech and biopharma, known for their expertise in the discovery, development, clinical design, and regulatory approval process of biologics, devices and combination products in the orthopedic, wound care, and plastic & reconstructive surgery markets. BCVG is now a department within Dark Horse Consulting (DHC) known as…

  • Medical Health Aged Care
  • 09/01/2026
  • 23:11
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs   BEIJING & ALAMEDA, Calif.…

  • Contains:
  • Medical Health Aged Care
  • 09/01/2026
  • 17:11
MRM Health NV

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.